| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536502 | Vaccine | 2017 | 9 Pages |
Abstract
OWEA influenza H5N1 virus monovalent vaccines exhibit broad cross-clade immunogenicity, a desired feature for vaccine stockpiling not yet demonstrated by unadjuvanted vaccines. In case of an impending H5N1 virus pandemic, stockpiled OWEA influenza H5N1 virus monovalent vaccines may allow population priming that could slow down the course of pandemic and could offer additional time needed for development of an effective strain specific vaccine supply.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kinnera E. Chada, Richard Forshee, Hana Golding, Steven Anderson, Hong Yang,